Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Reducing immune rejection related therapies using "stealth" technologies Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Biobanks are paving the way for personalised medicine Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Real World Evidence: Why is It Still Inferior In Evidence Hierarchies? Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Anti-aging therapies may have settled the argument of whether aging is a disease. Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 CRC: Australia's most significant accelerator program Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Towards the development of an off-the-shelf cure for cancer Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Leveraging Australia's existing foundation for impact Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Target Product Profile: starting that journey of a thousand miles with the right step Read More Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Success in Internationalisation is not only determined by technical prowess Read More Chih Wei Teng 27/2/25 Chih Wei Teng 27/2/25 Regulatory Engagement: Dialogue Over Delays Read More Chih Wei Teng 14/2/25 Chih Wei Teng 14/2/25 Australia’s Special Access Scheme - the lifeline for many. Read More Chih Wei Teng 30/1/25 Chih Wei Teng 30/1/25 Cell and Gene Therapies in Elite Sport - The Pinnacle of Human Evolution orthe Unnatural Demise of Fair Competition? Read More Chih Wei Teng 30/8/24 Chih Wei Teng 30/8/24 Was the decline in venture financing partially fuelled by a breakdown in the Triple Helix Innovation Model? Read More Chih Wei Teng 27/8/24 Chih Wei Teng 27/8/24 Internship Blog on Bias in Artificial Intelligence Read More Chih Wei Teng 28/9/23 Chih Wei Teng 28/9/23 Biotechnology sectors as shaped by different government approaches to investment Read More Chih Wei Teng 31/8/23 Chih Wei Teng 31/8/23 Learnings from First Nations traditional medicine could enhance the effectiveness of regenerative medicine. Read More Chih Wei Teng 22/8/23 Chih Wei Teng 22/8/23 Tools that help manage the complex process of commercialising cell and gene therapies and improve success Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Reducing immune rejection related therapies using "stealth" technologies Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Biobanks are paving the way for personalised medicine Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Real World Evidence: Why is It Still Inferior In Evidence Hierarchies? Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Anti-aging therapies may have settled the argument of whether aging is a disease. Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 CRC: Australia's most significant accelerator program Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Towards the development of an off-the-shelf cure for cancer Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Leveraging Australia's existing foundation for impact Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Target Product Profile: starting that journey of a thousand miles with the right step Read More
Chih Wei Teng 23/6/25 Chih Wei Teng 23/6/25 Success in Internationalisation is not only determined by technical prowess Read More
Chih Wei Teng 14/2/25 Chih Wei Teng 14/2/25 Australia’s Special Access Scheme - the lifeline for many. Read More
Chih Wei Teng 30/1/25 Chih Wei Teng 30/1/25 Cell and Gene Therapies in Elite Sport - The Pinnacle of Human Evolution orthe Unnatural Demise of Fair Competition? Read More
Chih Wei Teng 30/8/24 Chih Wei Teng 30/8/24 Was the decline in venture financing partially fuelled by a breakdown in the Triple Helix Innovation Model? Read More
Chih Wei Teng 27/8/24 Chih Wei Teng 27/8/24 Internship Blog on Bias in Artificial Intelligence Read More
Chih Wei Teng 28/9/23 Chih Wei Teng 28/9/23 Biotechnology sectors as shaped by different government approaches to investment Read More
Chih Wei Teng 31/8/23 Chih Wei Teng 31/8/23 Learnings from First Nations traditional medicine could enhance the effectiveness of regenerative medicine. Read More
Chih Wei Teng 22/8/23 Chih Wei Teng 22/8/23 Tools that help manage the complex process of commercialising cell and gene therapies and improve success Read More
